ABEO vs TDG · rev $20.1M vs P/E 41, rev $8.83B
Abeona Therapeutics Inc (ABEO) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ABEO currently screens at market cap $301.8M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ABEO and TDG stock pages for the full models.
Not investment advice.